Ellagic acid induces cell cycle arrest and apoptosis via the TGF‑β1/Smad3 signaling pathway in human colon cancer HCT‑116 cells

  • Authors:
    • Jinlu Zhao
    • Guodong Li
    • Jiufeng Wei
    • Shuwei Dang
    • Xiaotong Yu
    • Lixian Ding
    • Changquan Shang
    • Haopeng Zhang
    • Zhicheng Zhang
    • Hongsheng Chen
    • Ming Liu
  • View Affiliations

  • Published online on: May 20, 2020     https://doi.org/10.3892/or.2020.7617
  • Pages: 768-776
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal carcinoma (CRC) is a major type of malignancy worldwide. Ellagic acid (EA), a natural phenolic constituent, has been shown to exhibit anticancer effects. In our previous study, it was shown that EA inhibited proliferation of CRC cells. Additionally, microarray analysis revealed 4,738 differentially expressed genes (DEGs) which were associated with multiple cellular events, including cell growth, apoptosis and angiogenesis. However, the associated pathways had not been validated. In the present study, it was shown that EA induced G0/G1 cell cycle arrest in HCT‑116 cells, and increased apoptosis. Furthermore, DEGs identified by cDNA microarray analysis were investigated, and showed changes in five genes which were associated with the TGF‑β1/Smad3 signaling pathway. TGF‑β1 small interfering RNA and SIS3, a Smad3 inhibitor, were used to assess the role of TGF‑β1 and Smad3, respectively, and it was shown that the they reduced the effects of EA on HCT‑116 CRC cells. In addition, the expression patterns of downstream DEGs of the TGF‑β1/Smad3 pathway were altered. Thus, this pathway may underlie the molecular mechanism by which EA exhibits its effects in vitro in CRC cells. Accordingly, targeting the TGF‑β1/Smad3 pathway with anticancer agents such as EA may be potentially used to treat CRC.

Related Articles

Journal Cover

August-2020
Volume 44 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Zhao, J., Li, G., Wei, J., Dang, S., Yu, X., Ding, L. ... Liu, M. (2020). Ellagic acid induces cell cycle arrest and apoptosis via the TGF‑β1/Smad3 signaling pathway in human colon cancer HCT‑116 cells. Oncology Reports, 44, 768-776. https://doi.org/10.3892/or.2020.7617
MLA
Zhao, J., Li, G., Wei, J., Dang, S., Yu, X., Ding, L., Shang, C., Zhang, H., Zhang, Z., Chen, H., Liu, M."Ellagic acid induces cell cycle arrest and apoptosis via the TGF‑β1/Smad3 signaling pathway in human colon cancer HCT‑116 cells". Oncology Reports 44.2 (2020): 768-776.
Chicago
Zhao, J., Li, G., Wei, J., Dang, S., Yu, X., Ding, L., Shang, C., Zhang, H., Zhang, Z., Chen, H., Liu, M."Ellagic acid induces cell cycle arrest and apoptosis via the TGF‑β1/Smad3 signaling pathway in human colon cancer HCT‑116 cells". Oncology Reports 44, no. 2 (2020): 768-776. https://doi.org/10.3892/or.2020.7617